Decreased cell adhesion promotes angiogenesis in a Pyk2-dependent manner

Experimental Cell Research

Volumn 317, Issue 13, 2011, Pages 1860-1871

  Shen, Colette J ^a   Raghavan, Srivatsan ^a,b   Xu, Zhe ^a   Baranski, Jan D ^a   Yu, Xiang ^a   Wozniak, Michele A ^a   Miller, Jordan S ^a   Gupta, Mudit ^a   Buckbinder, Leonard ^c   Chen, Christopher S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

Angiogenesis; Cell adhesion; Gene expression; Pyk2; VEGF

Indexed keywords

FOCAL ADHESION KINASE 2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC ASSOCIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THREE DIMENSIONAL IMAGING; UPREGULATION;

MUS;

EID: 79959367226     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.05.006     Document Type: Article

References (65)

1. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8:464-478.
2. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
3. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
4. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
5. Miquerol L., Langille B.L., Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 2000, 127:3941-3946.
6. Ozawa C.R., Banfi A., Glazer N.L., Thurston G., Springer M.L., Kraft P.E., McDonald D.M., Blau H.M. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. 2004, 113:516-527.
7. Friedlander M., Brooks P.C., Shaffer R.W., Kincaid C.M., Varner J.A., Cheresh D.A. Definition of two angiogenic pathways by distinct alpha v integrins. Science 1995, 270:1500-1502.
8. Avraamides C.J., Garmy-Susini B., Varner J.A. Integrins in angiogenesis and lymphangiogenesis. Nat. Rev. Cancer 2008, 8:604-617.
9. Kim S., Bell K., Mousa S.A., Varner J.A. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 2000, 156:1345-1362.
10. Tanjore H., Zeisberg E.M., Gerami-Naini B., Kalluri R. Beta1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis. Dev. Dyn. 2008, 237:75-82.
11. Yang J.T., Rayburn H., Hynes R.O. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 1993, 119:1093-1105.
12. Ingber D.E. Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc. Natl Acad. Sci. U. S. A. 1990, 87:3579-3583.
13. Ingber D.E., Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J. Cell Biol. 1989, 109:317-330.
14. Re F., Zanetti A., Sironi M., Polentarutti N., Lanfrancone L., Dejana E., Colotta F. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol. 1994, 127:537-546.
15. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science 1997, 276:1425-1428.
16. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Micropatterned surfaces for control of cell shape, position, and function. Biotechnol. Prog. 1998, 14:356-363.
17. Huang S., Chen C.S., Ingber D.E. Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol. Biol. Cell 1998, 9:3179-3193.
18. Dike L.E., Chen C.S., Mrksich M., Tien J., Whitesides G.M., Ingber D.E. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cell. Dev. Biol. Anim. 1999, 35:441-448.
19. Pirone D.M., Liu W.F., Ruiz S.A., Gao L., Raghavan S., Lemmon C.A., Romer L.H., Chen C.S. An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling. J. Cell Biol. 2006, 174:277-288.
20. Aplin A.C., Fogel E., Zorzi P., Nicosia R.F. The aortic ring model of angiogenesis. Methods Enzymol. 2008, 443:119-136.
21. Miller J.S., Shen C.J., Legant W.R., Baranski J.D., Blakely B.L., Chen C.S. Bioactive hydrogels made from step-growth derived PEG-peptide macromers. Biomaterials 2010, 31:3736-3743.
22. Okigaki M., Davis C., Falasca M., Harroch S., Felsenfeld D.P., Sheetz M.P., Schlessinger J. Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proc. Natl Acad. Sci. U. S. A. 2003, 100:10740-10745.
23. Tan J.L., Liu W., Nelson C.M., Raghavan S., Chen C.S. Simple approach to micropattern cells on common culture substrates by tuning substrate wettability. Tissue Eng. 2004, 10:865-872.
24. Nelson C.M., Pirone D.M., Tan J.L., Chen C.S. Vascular endothelial-cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA. Mol. Biol. Cell 2004, 15:2943-2953.
25. Duong H., Wu B., Tawil B. Modulation of 3D fibrin matrix stiffness by intrinsic fibrinogen-thrombin compositions and by extrinsic cellular activity. Tissue Eng. Part A 2009, 15:1865-1876.
26. Ghajar C.M., Chen X., Harris J.W., Suresh V., Hughes C.C., Jeon N.L., Putnam A.J., George S.C. The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys. J. 2008, 94:1930-1941.
27. Mammoto A., Connor K.M., Mammoto T., Yung C.W., Huh D., Aderman C.M., Mostoslavsky G., Smith L.E., Ingber D.E. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 2009, 457:1103-1108.
28. Sieminski A.L., Hebbel R.P., Gooch K.J. The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp. Cell Res. 2004, 297:574-584.
29. Vailhe B., Ronot X., Tracqui P., Usson Y., Tranqui L. In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha(v)beta3 integrin localization. In Vitro Cell. Dev. Biol. Anim. 1997, 33:763-773.
30. Beamish J.A., Zhu J., Kottke-Marchant K., Marchant R.E. The effects of monoacrylated poly(ethylene glycol) on the properties of poly(ethylene glycol) diacrylate hydrogels used for tissue engineering. J. Biomed. Mater. Res. A 2010, 92:441-450.
31. Bell S.E., Mavila A., Salazar R., Bayless K.J., Kanagala S., Maxwell S.A., Davis G.E. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J. Cell Sci. 2001, 114:2755-2773.
32. Gerritsen M.E., Soriano R., Yang S., Ingle G., Zlot C., Toy K., Winer J., Draksharapu A., Peale F., Wu T.D., Williams P.M. In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set. Physiol. Genomics 2002, 10:13-20.
33. Zhang J., Hughes S. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J. Pathol. 2006, 208:453-461.
34. Zlot C., Ingle G., Hongo J., Yang S., Sheng Z., Schwall R., Paoni N., Wang F., Peale F.V., Gerritsen M.E. Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor. J. Biol. Chem. 2003, 278:47654-47659.
35. Collen A., Hanemaaijer R., Lupu F., Quax P.H., van Lent N., Grimbergen J., Peters E., Koolwijk P., van Hinsbergh V.W. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood 2003, 101:1810-1817.
36. Hiraoka N., Allen E., Apel I.J., Gyetko M.R., Weiss S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998, 95:365-377.
37. Yasui M., Yamamoto H., Ngan C.Y., Damdinsuren B., Sugita Y., Fukunaga H., Gu J., Maeda M., Takemasa I., Ikeda M., Fujio Y., Sekimoto M., Matsuura N., Weinstein I.B., Monden M. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization. Clin. Cancer Res. 2006, 12:4720-4729.
38. Eliceiri B.P., Puente X.S., Hood J.D., Stupack D.G., Schlaepfer D.D., Huang X.Z., Sheppard D., Cheresh D.A. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J. Cell Biol. 2002, 157:149-160.
39. Braren R., Hu H., Kim Y.H., Beggs H.E., Reichardt L.F., Wang R. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J. Cell Biol. 2006, 172:151-162.
40. Shen T.L., Park A.Y., Alcaraz A., Peng X., Jang I., Koni P., Flavell R.A., Gu H., Guan J.L. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J. Cell Biol. 2005, 169:941-952.
41. Avraham H.K., Lee T.H., Koh Y., Kim T.A., Jiang S., Sussman M., Samarel A.M., Avraham S. Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase. J. Biol. Chem. 2003, 278:36661-36668.
42. Weis S.M., Lim S.T., Lutu-Fuga K.M., Barnes L.A., Chen X.L., Gothert J.R., Shen T.L., Guan J.L., Schlaepfer D.D., Cheresh D.A. Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK. J. Cell Biol. 2008, 181:43-50.
43. Lev S., Moreno H., Martinez R., Canoll P., Peles E., Musacchio J.M., Plowman G.D., Rudy B., Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 1995, 376:737-745.
44. Zheng C., Xing Z., Bian Z.C., Guo C., Akbay A., Warner L., Guan J.L. Differential regulation of Pyk2 and focal adhesion kinase (FAK). The C-terminal domain of FAK confers response to cell adhesion. J. Biol. Chem. 1998, 273:2384-2389.
45. Avraham S., London R., Fu Y., Ota S., Hiregowdara D., Li J., Jiang S., Pasztor L.M., White R.A., Groopman J.E., Avraham H. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J. Biol. Chem. 1995, 270:27742-27751.
46. Sasaki H., Nagura K., Ishino M., Tobioka H., Kotani K., Sasaki T. Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J. Biol. Chem. 1995, 270:21206-21219.
47. van Buul J.D., Anthony E.C., Fernandez-Borja M., Burridge K., Hordijk P.L. Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation. J. Biol. Chem. 2005, 280:21129-21136.
48. Matsui A., Okigaki M., Amano K., Adachi Y., Jin D., Takai S., Yamashita T., Kawashima S., Kurihara T., Miyazaki M., Tateishi K., Matsunaga S., Katsume A., Honshou S., Takahashi T., Matoba S., Kusaba T., Tatsumi T., Matsubara H. Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function. Circulation 2007, 116:1041-1051.
49. Tang H., Hao Q., Fitzgerald T., Sasaki T., Landon E.J., Inagami T. Pyk2/CAKbeta tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells. J. Biol. Chem. 2002, 277:5441-5447.
50. Bonnette P.C., Robinson B.S., Silva J.C., Stokes M.P., Brosius A.D., Baumann A., Buckbinder L. Phosphoproteomic characterization of PYK2 signaling pathways involved in osteogenesis. J. Proteomics 2010, 73:1306-1320.
51. Slack-Davis J.K., Martin K.H., Tilghman R.W., Iwanicki M., Ung E.J., Autry C., Luzzio M.J., Cooper B., Kath J.C., Roberts W.G., Parsons J.T. Cellular characterization of a novel focal adhesion kinase inhibitor. J. Biol. Chem. 2007, 282:14845-14852.
52. Ferrara N., Kerbel R.S. Angiogenesis as a therapeutic target. Nature 2005, 438:967-974.
53. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., Reinhart-King C.A., Margulies S.S., Dembo M., Boettiger D., Hammer D.A., Weaver V.M. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254.
54. Reynolds A.R., Hart I.R., Watson A.R., Welti J.C., Silva R.G., Robinson S.D., Da Violante G., Gourlaouen M., Salih M., Jones M.C., Jones D.T., Saunders G., Kostourou V., Perron-Sierra F., Norman J.C., Tucker G.C., Hodivala-Dilke K.M. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat. Med. 2009, 15:392-400.
55. Yana I., Sagara H., Takaki S., Takatsu K., Nakamura K., Nakao K., Katsuki M., Taniguchi S., Aoki T., Sato H., Weiss S.J., Seiki M. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. J. Cell Sci. 2007, 120:1607-1614.
56. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., Jeltsch M., Mitchell C., Alitalo K., Shima D., Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 2003, 161:1163-1177.
57. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005, 69(Suppl 3):4-10.
58. Guan J.L., Trevithick J.E., Hynes R.O. Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul. 1991, 2:951-964.
59. Gilmore A.P., Romer L.H. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol. Biol. Cell 1996, 7:1209-1224.
60. Parsons J.T. Focal adhesion kinase: the first ten years. J. Cell Sci. 2003, 116:1409-1416.
61. Holmes D.I., Zachary I.C. Vascular endothelial growth factor regulates stanniocalcin-1 expression via neuropilin-1-dependent regulation of KDR and synergism with fibroblast growth factor-2. Cell. Signal. 2008, 20:569-579.
62. Avraham H., Park S.Y., Schinkmann K., Avraham S. RAFTK/Pyk2-mediated cellular signalling. Cell. Signal. 2000, 12:123-133.
63. Brizzi M.F., Defilippi P., Rosso A., Venturino M., Garbarino G., Miyajima A., Silengo L., Tarone G., Pegoraro L. Integrin-mediated adhesion of endothelial cells induces JAK2 and STAT5A activation: role in the control of c-fos gene expression. Mol. Biol. Cell 1999, 10:3463-3471.
64. Dudley A.C., Thomas D., Best J., Jenkins A. A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia. Biochem. J. 2005, 390:427-436.
65. Shaut C.A., Saneyoshi C., Morgan E.A., Knosp W.M., Sexton D.R., Stadler H.S. HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. Dev. Dyn. 2007, 236:951-960.